IP Library › Granted Patent US 11,208,686
Granted Patent B2
US 11,208,686 · App. 16/493,173 · Granted Dec 28, 2021

Reagent for extracting and amplifying nucleic acid

Inventor: Hiroshi Sato (Kanagawa, JP)
Assignee: TOSOH CORPORATION
C12Q1/6848C07J41/0027C08B30/18C08B37/0012C12N15/1003C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,208,686
App. No.
16/493,173
Granted
Dec 28, 2021
Kind
B2
Abstract

The present invention addresses the problem of providing a reagent for extracting/amplifying a nucleic acid of a nucleic acid extraction target, the reagent being characterized in that a nucleic acid is conveniently extracted quickly and efficiently from the nucleic acid extraction target and inhibition of a nucleic acid amplification reaction is minimized, and the problem of providing a method for extracting or amplifying a nucleic acid using said reagent. The problems are solved by using a kit for extracting and amplifying a nucleic acid of a nucleic acid extraction target from a sample containing the nucleic acid extraction target, the kit including (i) a nucleic acid extraction reagent containing at least a surfactant having a steroid skeleton, (ii) γ-cyclodextrin having a C1-4 hydroxyalkyl group, and (iii) a nucleic acid amplification reagent.

Claims (23)

1. A kit for extracting and amplifying a nucleic acid of a nucleic acid extraction target from a sample containing the nucleic acid extraction target, comprising (i), (ii) and (iii), wherein the nucleic acid extraction target is selected from microorganisms, animal cells, plant cells, and extracellular vesicles:

(i) a nucleic acid extraction reagent, containing at least a surfactant with a steroid skeleton;

(ii) γ-cyclodextrin having a C1-4 hydroxyalkyl group, wherein said γ-cyclodextrin having a C1-4 hydroxyalkyl group is 2-hydroxypropyl-γ-cyclodextrin; and

(iii) a nucleic acid amplification reagent.

2. The kit according to claim 1 , wherein the γ-cyclodextrin having a C1-4 hydroxyalkyl group is contained in the nucleic acid amplification reagent.

3. The kit according to claim 1 , wherein the concentration of the γ-cyclodextrin having a C1-4 hydroxyalkyl group is 4 or more times the concentration of the surfactant with a steroid skeleton.

4. The kit according to claim 1 , wherein the nucleic acid extraction target is a microorganism.

5. A method for extracting and amplifying a nucleic acid of a nucleic acid extraction target from a sample containing the nucleic acid extraction target, comprising (i), (ii) and (iii), wherein the nucleic acid extraction target is selected from microorganisms, animal cells, plant cells, and extracellular vesicles:

(i) extracting the nucleic acid, which involves contacting a sample containing a nucleic acid extraction target with a nucleic acid extraction reagent containing at least a surfactant with a steroid skeleton, thereby obtaining a nucleic acid extract;

(ii) contacting the nucleic acid extract obtained in (i) with γ-cyclodextrin having a C1-4 hydroxyalkyl group, wherein said γ-cyclodextrin having a C1-4 hydroxyalkyl group is 2-hydroxypropyl-γ-cyclodextrin; and

(iii) amplifying the nucleic acid, which involves contacting the solution obtained in (ii) with a nucleic acid amplification reagent.

6. A method for extracting and amplifying a nucleic acid of a nucleic acid extraction target from a sample containing the nucleic acid extraction target, comprising (i) and (ii), wherein

the nucleic acid extraction target is selected from microorganisms, animal cells, plant cells, and extracellular vesicles:

(i) extracting the nucleic acid, which involves contacting a sample containing the nucleic acid extraction target with a nucleic acid extraction reagent containing at least a surfactant with a steroid skeleton, thereby obtaining a nucleic acid extract; and

(ii) amplifying the nucleic acid, which involves contacting the nucleic acid extract obtained in (i) with a nucleic acid amplification reagent containing γ-cyclodextrin having a C1-4 hydroxyalkyl group, wherein said γ-cyclodextrin having a C1-4 hydroxyalkyl group is 2-hydroxypropyl-γ-cyclodextrin.

7. The method according to claim 5 , wherein the nucleic acid extraction target is a microorganism.

8. The method according to claim 6 , wherein the nucleic acid extraction target is a microorganism.

9. The kit according to claim 1 , wherein the surfactant with a steroid skeleton is at least one selected from the group consisting of cholic acid, taurocholic acid, glycocholic acid, tauroursodeoxycholic, and salts thereof.

10. The method according to claim 5 , wherein the surfactant with a steroid skeleton is at least one selected from the group consisting of cholic acid, taurocholic acid, glycocholic acid, tauroursodeoxycholic, and salts thereof.

11. The method according to claim 6 , wherein the surfactant with a steroid skeleton is at least one selected from the group consisting of cholic acid, taurocholic acid, glycocholic acid, tauroursodeoxycholic, and salts thereof.

12. The kit according to claim 1 , wherein the surfactant with a steroid skeleton is sodium cholate.

13. The method according to claim 5 , wherein the surfactant with a steroid skeleton is sodium cholate.

14. The method according to claim 6 , wherein the surfactant with a steroid skeleton is sodium cholate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2019
From: SATO, HIROSHI
To: TOSOH CORPORATION
Reel/Frame 050344/0660 →
Priority Claims (3)
JP JP2017-047428 · Mar 13, 2017 · national
JP JP2017-097209 · May 16, 2017 · national
JP JP2017-215697 · Nov 8, 2017 · national
Continuity (1)
Related Publication 20200140924A1 · May 7, 2020